(Q40072292)

17 September 2017

title

IgG-, IgA- and IgM-antibodies to herpes simplex virus type 2 in sera from patients with cancer of the uterine cervix (English)

1 reference

https://api.crossref.org/works/10.1016/0014-2964(77)90212-2

28 May 2022

author name string

I. H. El Falaky

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A193693

28 May 2022

B. F. Vestergaard

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A193693

28 May 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=193693

28 May 2022

publication date

1 March 1977

1 reference

17 September 2017

29 March 1977

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=193693

full work available at URL

28 May 2022

https://api.elsevier.com/content/article/PII:0014296477902122?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0014-2964(77)90212-2

https://api.elsevier.com/content/article/PII:0014296477902122?httpAccept=text/plain

28 May 2022

1 reference

https://api.crossref.org/works/10.1016/0014-2964(77)90212-2

European Journal of Cancer

28 May 2022

published in

1 reference

17 September 2017

volume

13

1 reference

17 September 2017

issue

3

1 reference

17 September 2017

page(s)

247-251

1 reference

Infection with herpes-simplex viruses 1 and 2. II.

17 September 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0014-2964(77)90212-2

Infection with herpes-simplex viruses 1 and 2. 3.

28 May 2022

2

1 reference

https://api.crossref.org/works/10.1016/0014-2964(77)90212-2

The causative role of herpesvirus type 2 in cervical cancer

28 May 2022

3

1 reference

https://api.crossref.org/works/10.1016/0014-2964(77)90212-2

Occurrence of herpes- and adenovirus antibodies in patients with carcinoma of the cervix uteri. Measurement of antibodies to herpesvirus hominis (types 1 and 2), cytomegalovirus, EB-virus, and adenovirus

28 May 2022

4

1 reference

https://api.crossref.org/works/10.1016/0014-2964(77)90212-2

IgG, IgA and IgM antibody responses in patients with acute genital and non-genital herpetic lesions determined by the indirect fluorescent antibody method

28 May 2022

6

1 reference

https://api.crossref.org/works/10.1016/0014-2964(77)90212-2

Specific IgG and IgM antibody responses in herpes-simplex-virus infections

28 May 2022

8

1 reference

https://api.crossref.org/works/10.1016/0014-2964(77)90212-2

Determination of different cytomegalovirus immunoglobulins (IgG, IgA, IgM) by immunofluorescence

28 May 2022

9

1 reference

https://api.crossref.org/works/10.1016/0014-2964(77)90212-2

IgG, IgA and IgM responses in acute rubella determined by the immunofluorescent technique

28 May 2022

10

1 reference

https://api.crossref.org/works/10.1016/0014-2964(77)90212-2

Herpesvirus type 2-related antigens and their relevance to humoral and cell-mediated immunity in patients with cervical cancer

28 May 2022

11

1 reference

https://api.crossref.org/works/10.1016/0014-2964(77)90212-2

Comparison of neutralizing and immunoprecipitating activity in guinea pig antisera against Herpes simplex virus types 1 and 2

28 May 2022

12

1 reference

https://api.crossref.org/works/10.1016/0014-2964(77)90212-2

An evaluation of humoral antibody responses in patients with carcinoma of the cervix

28 May 2022

Increasing antibody titers to herpes simplex virus type 2 during follow-up of women with cervical dysplasia

14

0 references

15

1 reference

https://api.crossref.org/works/10.1016/0014-2964(77)90212-2

28 December 2022

Identifiers

1 reference

17 September 2017

1 reference